Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma is a research paper published in Clinical & Experimental Allergy (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: U10 HL109164
National Heart, Lung, and Blood Institute
Grant: U10 HL109257
National Heart, Lung, and Blood Institute
Grant: U10 HL109146
National Heart, Lung, and Blood Institute
Grant: U10 HL109172
National Heart, Lung, and Blood Institute
Grant: U10 HL109250
National Heart, Lung, and Blood Institute
Grant: U10 HL109168
National Heart, Lung, and Blood Institute
Grant: U10 HL109152
National Heart, Lung, and Blood Institute
Grant: U10 HL109086
National Heart, Lung, and Blood Institute
Grant: R01 HL122426
National Institutes of Health
Grant: 5R01HL122426-03
Immunopathogenesis in fungal asthma
National Institutes of Health
Grant: 5U10HL109164-04
Longitudinal Phenomics and Genetics of Severe Asthma
National Institutes of Health
Grant: 5U10HL109172-03
AMSA: ALXR/FBR Mediated Signaling in Severe Asthma
National Institutes of Health
Grant: 5U10HL109152-02
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma
National Institutes of Health
Grant: 5U10HL109146-05
Clinical and Molecular Phenotypes of Severe Asthma
National Institutes of Health
Grant: 4U10HL109168-06
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
National Institutes of Health
Grant: 4U10HL109257-06
Severe Asthma Research Program (SARP)-Washington University
National Institutes of Health
Grant: 1U10HL109250-01
Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*
National Institutes of Health
Grant: 5U10HL109086-05
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
Regeneron Pharmaceuticals
MedImmune
Sanofi
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
Genentech
AstraZeneca
FWCI
2.94
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals